Research products
SS-31
EUR 39.95
Product Overview
Research use only
SS-31 is the development name for elamipretide, a mitochondria-targeting tetrapeptide commonly represented as D-Arg-Dmt-Lys-Phe-NH2 (Dmt = 2,6-dimethyltyrosine). It interacts with mitochondrial membranes/cardiolipin-related processes and has been studied in mitochondrial bioenergetics, oxidative stress, aging and muscle/cardiac models.
Product information
Research classification: mitochondria-targeted tetrapeptide. In September 2025, the FDA granted accelerated approval to elamipretide (Forzinity) for Barth syndrome in patients meeting the approved criteria, providing regulatory validation for a specific finished drug product and indication.